Endologix Inc
ELGX
ELGX was delisted on the 15th of July, 2020.
152 hedge funds and large institutions have $1.2B invested in Endologix Inc in 2016 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 59 increasing their positions, 46 reducing their positions, and 25 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
28% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 46
4% more capital invested
Capital invested by funds: $1.15B → $1.2B (+$49.6M)
7% less funds holding
Funds holding: 163 → 152 (-11)
40% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 25
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $330K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$12.8M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$12.6M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$9.85M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$9.46M |
| 5 |
ECP
Elk Creek Partners
Denver,
Colorado
|
+$8.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$25.6M |
| 2 |
CCM
Cadian Capital Management
New York
|
-$15.2M |
| 3 |
Goldman Sachs
New York
|
-$13.6M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$13.1M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$6.17M |
ELGX Hedge Fund Activity: Q3 2016 in Review
152 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Endologix Inc (ELGX) for Q3 2016, worth a combined $1.2B — up 4.3% from $1.15B a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of ELGX and 15 opened new positions — a net loss of 10 holders — while 46 trimmed existing stakes and 59 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $12.8M. The largest seller was Camber Capital Management, cutting an estimated $25.6M.
- 152 institutional investors held Endologix Inc (ELGX) as of Q3 2016, down from 163 in Q2 2016.
- Funds reported $1.2B of Endologix Inc stock for Q3 2016, up 4.3% quarter-over-quarter.
- 15 funds opened new Endologix Inc positions in Q3 2016 and 25 closed out, a net change of -10 holders.
- The largest Endologix Inc buyer in Q3 2016 was T. Rowe Price Associates, an estimated $12.8M added.
- The largest Endologix Inc seller in Q3 2016 was Camber Capital Management, an estimated $25.6M sold.
Based on aggregated 13F filings for Q3 2016.